Two siRNAs were used to inhibit MLKL expression in BC cells (Figure 2(a), right), and the results revealed that cell death induced by SBP-0636457/Dox/z.VAD markedly reduced after MLKL knockdown in BC cells (Figure 2(d)). The gene discussed is MLKL; the disease is breast cancer.